Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Genentech Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 58
» View ktuu.com items only
    May 12, 2013 |Story| Los Angeles Times

  1. Bill would regulate 'biosimilar' drugs

    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...

    Tags: Exports, Roche Holding AG, Imports, Chemical Industry, Pharmaceuticals

    2. May 2, 2013 |Story| South Florida Sun-Sentinel

  2. International consortium releases hepatitis C data

    Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...

    Tags: Liver Disease, Health and Safety at School, Symptoms, Colleges and Universities, Liver Cancer

    3. Apr 29, 2013 |Story| Allentown Morning Call

  3. Passenger on flight out of Philly detained for not flushing toilet

    PHILADELPHIA — A passenger who flew from Philadelphia to San Francisco was detained on arrival by federal agents after a vindictive flight attendant claimed he had not flushed a lavatory toilet, according to a federal suit. The suit, which seeks...

    Tags: Virgin Group, Ltd., FBI

    4. Apr 25, 2013 |Story| Los Angeles Times

  4. HIV vaccine trial shut down

    In another major setback for efforts to develop an HIV vaccine, federal researchers have shut down a key clinical trial after an independent panel of safety experts determined that volunteers who got an experimental vaccine appeared to be slightly more...

    Tags: Placebo, Chemical Industry, Columbia University, Viral Diseases and Infections, HIV

    5. Apr 24, 2013 |Story| Chicago Tribune

  5. Boeing, billionaire Penny Pritzker among Obama's donors

    Illinois donors to President Barack Obama’s second inauguration included aviation giant Boeing Co., which contributed $1 million, and billionaire Penny Pritzker, who gave $250,000, according to newly filed records.
    Tribune reporter
    Illinois donors to President Barack Obama’s second inauguration included aviation giant Boeing Co., which contributed $1 million, and billionaire Penny Pritzker, who gave $250,000, according to newly filed records. Pritzker, who is being vetted by...

    Tags: Federal Election Commission, Mike Quigley, Brad Schneider, Entertainment, Microsoft Corporation

    6. Apr 22, 2013 |Story| Los Angeles Times

  6. Major corporations backed inaugural festivities

    WASHINGTON — President Obama's second inaugural committee raised a little more than $43 million to put on the official festivities surrounding his January swearing-in, backed by major donations from some of the country's biggest corporations,...

    Tags: Washington, DC, Career and Workplace, Federal Election Commission, Labor Legislation, Bank of America Corp.

    7. Apr 19, 2013 |Story| Los Angeles Times

  7. Strategies for cutting the cost of prescription drugs

    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it.
    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...

    Tags: Insurance, Employment, Career and Workplace, Cedars-Sinai Medical Center, Chemical Industry

    8. Mar 29, 2013 |Story| Los Angeles Times

  8. Remove Medicare's straitjacket

    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although raising the age of Medicare eligibility from 65 to 67 appears off the table, at least for now, the budget plan that Rep. Paul D. Ryan (R-Wis.) is proposing would shift a greater share of the program's growing costs to beneficiaries in the years to come.
    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...

    Tags: Paul Ryan, Chemical Industry, Private Health Care, Medicare, Dialysis

    9. Mar 17, 2013 |Story| Los Angeles Times

  9. Battle over 'biosimilars'

    One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies what amounts to a 12-year monopoly on the substances they developed. Now, supporters of biologics are pushing lawmakers in Sacramento and other state capitals to put new hurdles in the way of knock-off compounds, called "biosimilars."
    One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies...

    Tags: Crime, Law and Justice, Chemical Industry, Biotechnology Industry, General Practitioners, Vaccines

    10. Mar 6, 2013 |Story| Los Angeles Times

  10. Facebook is about to redesign News Feed: Here's what to expect

    SAN FRANCISCO -- Facebook is rolling out a radical new redesign of News Feed, the biggest since it launched the feature in 2006.
    SAN FRANCISCO -- Facebook is rolling out a radical new redesign of News Feed, the biggest since it launched the feature in 2006. The giant social network plans to unveil the redesign at a press conference Thursday at its Menlo Park, Calif.,...

    Tags: Social Media, Chemical Industry, Biotechnology Industry, George Takei, Companies and Corporations

    11. Mar 3, 2013 |Story| Baltimore Sun

  11. Asthma drug calms chronic hives, rashes

    Sufferers of chronic hives and rashes could benefit from a commonly-used asthma drug, Johns Hopkins researchers have found. Scientists found that a once-a-month dose of the drug omalizumab helped ease symptoms that standard antihistamines didn't....

    Tags: Skin Rash, Asthma, Symptoms, Novartis AG, Medical Research

    12. Jan 18, 2013 |Story| Aberdeen News

  12. CDC: Flu season `bad one for the elderly'

    The number of older people hospitalized with the flu has risen sharply, prompting federal officials to take unusual steps to make more flu medicines available and to urge wider use of them as soon as symptoms appear.  The U.S. is about halfway through...

    Tags: Brooklyn (New York City), Tamiflu (drug), Symptoms, Epidemics and Plagues, Viral Diseases and Infections

 1  2 3 4 5 • Next >
Original site for Genentech Inc. topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Genentech Inc. Photos
Some firms seek to make "biosimilar" drugs that would p...
(April 25, 2013)
Bill would regulate ‘biosimilar’ drugs
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC
Lisa Harris Jones, of the firm Harris Jones Malone, has...
(March 20, 2003)
No. 3: Lisa Harris Jones